화학공학소재연구정보센터
검색결과 : 43건
No. Article
1 Radiolabeling of Biogenic Magnetic Nanoparticles with Rhenium-188 as a Novel Agent for Targeted Radiotherapy
Akbari-Karadeh S, Aghamiri SMR, Tajer-Mohammad-Ghazvini P, Ghorbanzadeh-Mashkani S
Applied Biochemistry and Biotechnology, 190(2), 540, 2020
2 Engineered Fn3 protein has targeted therapeutic effect on mesothelin-expressing cancer cells and increases tumor cell sensitivity to chemotherapy
Sirois AR, Deny DA, Li YX, Fall YD, Moore SJ
Biotechnology and Bioengineering, 117(2), 330, 2020
3 LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years
Tam C, Wong JH, Tsui SKW, Zuo T, Chan TF, Ng TB
Applied Microbiology and Biotechnology, 103(12), 4649, 2019
4 p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration
Chen XF, Pan YS, Zheng B, Lu Q
Biochemical and Biophysical Research Communications, 516(2), 466, 2019
5 EphA2 inhibition suppresses proliferation of small-cell lung cancer cells through inducing cell cycle arrest
Ishigaki H, Minami T, Morimura O, Kitai H, Horio D, Koda Y, Fujimoto E, Negi Y, Nakajima Y, Niki M, Kanemura S, Shibata E, Mikami K, Takahashi R, Yokoi T, Kuribayashi K, Kijima T
Biochemical and Biophysical Research Communications, 519(4), 846, 2019
6 Drug-induced expression of the RNA-binding protein HuR attenuates the adaptive response to BRAF inhibition in melanoma
Merat R, Bugi-Marteyn A, Wrobel LJ, Py C, Daali Y, Schwarzler C, Liaudet N
Biochemical and Biophysical Research Communications, 517(2), 181, 2019
7 Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer
Wang MR, Liu WH, Zhang YQ, Dang M, Zhang YL, Tao J, Chen K, Peng X, Teng ZG
Journal of Colloid and Interface Science, 538, 630, 2019
8 The anti-osteosarcoma cell activity by a mTORC1/2 dual inhibitor RES-529
Hu XJ, Wang ZR, Chen MK, Chen XR, Liang WQ
Biochemical and Biophysical Research Communications, 497(2), 499, 2018
9 Inhibition of CX(3)CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells
Stout MC, Narayan S, Pillet ES, Salvino JM, Campbell PM
Biochemical and Biophysical Research Communications, 495(3), 2264, 2018
10 AZD5153, a novel BRD4 inhibitor, suppresses human thyroid carcinoma cell growth in vitro and in vivo
Xu K, Chen DX, Qian D, Zhang SH, Zhang Y, Guo S, Ma ZQ, Wang S
Biochemical and Biophysical Research Communications, 499(3), 531, 2018